Resources
691 - 705 of
957 Results
Sort Results:
Commentary:
Champix (Varenicline): Potential Cardiovascular Risks In Patients With Heart Disease
August 2011
Article:
Drug interactions continue to be a source of problems with phosphodiesterase 5 (PDE5) inhibitors
August 2011